This bid is closed — responses were due September 15, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is for pharmacogenomic analysis services for participants in the STAR-B clinical trial, which is studying semaglutide for alcohol use disorder. The services will involve genetic testing and analysis to understand how participants' genes influence their response to the treatment.
Sign up free to see the agency name and the original bid posting link. Pro adds the 2 documents, contracting-officer contacts and AI response outlines.